Related Experiment Video

Updated: May 26, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Increasing potential of HER3 signaling in colon cancer progression and therapy

Christian Gespach1

  • 1Institut National de la Santé et de la Recherche Médicale U938, Paris 6 Université Pierre et Marie Curie, and Department of Molecular and Clinical Oncology, Hôpital Saint-Antoine, Paris, France. christian.gespach@inserm.fr

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|December 30, 2011
PubMed

Insights

High HER3 protein levels in colorectal cancer correlate with poor patient survival. Blocking HER3 hinders cancer cell growth and invasion, enhancing chemotherapy effectiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • HER3 protein expression on the plasma membrane is linked to decreased survival in colorectal cancer patients.
  • HER3 signaling pathways play a role in cancer cell proliferation and metastasis.

Purpose of the Study:

  • To investigate the impact of HER3 blockade on colorectal cancer cell behavior.
  • To evaluate HER3 as a therapeutic target in colorectal cancer.

Main Methods:

  • Assessing HER3 protein levels in colorectal cancer cells.
  • Implementing HER3 blockade strategies.
  • Analyzing cellular growth, survival, migration, and invasion.
  • Evaluating the combined effect of HER3 blockade and 5-FU chemotherapy.

Main Results:

  • HER3 protein levels at the cancer cell plasma membrane are directly correlated with reduced patient survival.
  • HER3 blockade resulted in G(2)-M cell cycle arrest, restricting cellular growth.
  • HER3 blockade inhibited cancer cell survival, migration, and invasion.
  • HER3 blockade potentiated the chemotherapeutic effect of 5-FU.

Conclusions:

  • Targeting HER3 is a promising strategy for subsets of colorectal cancer patients.
  • HER3 blockade demonstrates significant anti-cancer effects in colorectal cancer models.
  • Combined HER3-targeted therapy and chemotherapy may improve treatment outcomes.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...